Azure Biotech, Inc. — Form D
Azure Biotech, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-07. The offering totals $2.0M, of which $355K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-01-07
- Form: D
- Accession: 0001630005-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $355K
- Remaining: $1.6M
- Investors: 8
- Date of first sale: 2014-12-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-231608
Issuer
- Name: Azure Biotech, Inc.
- CIK: 0001630005
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 500 East 85th Street, New York, NY, 10025
- Phone: 917-747-9591
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Valerie A Ceva | Director | Portland, OR |
| Steven R Goldstein | Director | New York, NY |
| Susan A Levinson | Director | Portland, OR |
| David D Thompson | Director | Portland, OR |
| Valerie A Ceva | Executive Officer | Portland, OR |
| Ralph Makar | Executive Officer | Portland, OR |
| Valerie Ceva | Director | Morristown, NJ |
| Valerie Ceva | Executive Officer | Morristown, NJ |
| Susan Levinson | Director | Morristown, NJ |
Other filings by this issuer (1)
More